drugset

drugset / Trial / NCT01859481

Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study

NCT01859481 ↗

Phase 3 Completed 971 enrolled Viatris Inc.

RandomizedParallel-groupDouble-blindTreatment

Summary

Evaluation of headache response at 2 hours for active treated attacks for increasing dose.

Timeline

Start: 2000-03
Primary completion: 2002-03
Completion: 2002-03

Publications

Almas M, Tepper SJ, Landy S, Schweizer E, Ramos E. Consistency of eletriptan in treating migraine: Results of a randomized, within-patient multiple-dose study. Cephalalgia. 2014 Feb;34(2):126-35. doi: 10.1177/0333102413500726. Epub 2013 Aug 14.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Eletriptan	Small molecule	40 mg	—
Subject	Eletriptan	Small molecule	80 mg	—

Indications